A Novel, Orally Delivered Antibody Therapy and Its Potential to Prevent Clostridioides difficile Infection in Pre-clinical Models

Clostridioides difficile infection (CDI) is a toxin-mediated infection in the gut and a major burden on healthcare facilities worldwide. We rationalized that it would be beneficial to design an antibody therapy that is delivered to, and is active at the site of toxin production, rather than neutrali...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Front Microbiol
Hoofdauteurs: Roberts, April K., Harris, Hannah C., Smith, Michael, Giles, Joanna, Polak, Oktawia, Buckley, Anthony M., Clark, Emma, Ewin, Duncan, Moura, Ines B., Spitall, William, Shone, Clifford C., Wilcox, Mark, Chilton, Caroline, Donev, Rossen
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Frontiers Media S.A. 2020
Onderwerpen:
Microbiology
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7537341/
https://ncbi.nlm.nih.gov/pubmed/33072047
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmicb.2020.578903
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items